Cognitive and Psychiatric Characteristics of Huntington Disease. Rosa Ip, PhD, C. Psych, Jean Byers. MD., FRCPC, DABPN, Carol Harren, RN, CNC

Similar documents
Korean-VCI Harmonization Standardization- Neuropsychology Protocol (K-VCIHS-NP)

CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE

NEUROPSYCHOMETRIC TESTS

Cognitive Impairment in AOD: Assessment and Treatment

PPMI Cognitive-Behavioral Working Group. Daniel Weintraub, MD

Neuroscience 410 Huntington Disease - Clinical. March 18, 2008

What APS Workers Need to Know about Frontotemporal, Lewy Body and Vascular Dementias

International Forum on HIV and Rehabilitation Research

Detecting neurocognitive impairment in HIV-infected youth: Are we focusing on the wrong factors?

Hunting for Huntington s

Huntington s Disease Psychiatry. Christopher A. Ross MD PhD HDSA Convention June 6, Many slides adapted from Adam Rosenblatt, MD

CRITICALLY APPRAISED PAPER (CAP)

Managing Challenging Behaviors

Psychiatric Issues in Patients with Huntington's Disease. Disclosures. Huntington s Disease. Disease Course. Huntington s Disease

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Managing Challenging Behaviors

White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration

22q11.2 Deletion Syndrome Fact Sheet - Treatable Psychiatric Illnesses in Adults

Number of Items. Response Categories. Part V: Specific Behavior Scales-Sleep Scales. Based on past month

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia

9/24/2012. Amer M Burhan, MBChB, FRCP(C)

QUESTIONNAIRE: Finland

Youthdale Treatment Centres

The Spectrum of Lewy Body Disease: Dementia with Lewy Bodies and Parkinson's Disease Dementia

HD 101: Cognition and HD. Daniel O. Claassen, MD MS Assistant Professor of Neurology Director: HD and Chorea Clinic Vanderbilt University

CONSULTATION / LIAISON PSYCHIATRY

Cover Page. The handle holds various files of this Leiden University dissertation

Service Related Project. Kimberley Keegan

Concise Reference Cognitive Dysfunction in Schizophrenia Richard Keefe, Martin Lambert, Dieter Naber

NBRHC Regional Programs

Final Report of Activity February 21 st, 2006 to April 30 th, 2006 CHEO Grant 052

Translational Clinical Science

21/05/2018. Today s webinar will answer. Presented by: Valorie O Keefe Consultant Psychologist

Improving clinical management and quality of life in mid to late stage Huntington s disease How research can inform clinical practice and vice versa

Nature, prevalence and clinical significance. Barcelona, Spain

Learning objectives 6/20/2018

GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT

Don t wait-and-see, research suggests

Key words: Huntington s disease, apathy, cognition, depression, companion, self-rated,

CRASH COURSE IN OUTCOMES

I Can t Think Properly Brian Fog & POTS

Asperger s Syndrome facts What is wrong with our current understanding of AS Current research project Where to go from here

Table 7.2B: Summary of Select Screening Tools for Assessment of Vascular Cognitive Impairment in Stroke Patients

Psychiatric and Behavioral Challenges in HD

Multiple sclerosis : how cognitive performance relates to quality of life, depression, and perception of deficits

Neuropsychiatric Manifestations in Vascular Cognitive Impairment Patients with and without Dementia

Range of neuropsychiatric disturbances in patients with Parkinson s disease

Montreal Cognitive Assessment (MoCA) Overview for Best Practice in Stroke and Complex Neurological Conditions March 2013

Biological Risk Factors

GERIATRIC PSYCHIATRY: TREATING DEPRESSION AND ANXIETY

Karen G. Pounds PhD, APRN, BC Northeastern University Bouve College School of Nursing Boston, Massachusetts

October 28, Geriatrics Update Course. Lesley Wiesenfeld, MD, MHCM, FRCPC. Managing BPSD. Geriatric Psychiatrist, Mount Sinai Hospital

Neuropsychiatric Syndromes

SLEEP DISORDERS IN HUNTINGTON S DISEASE. Gary L. Dunbar, Ph.D.

NEUROBEHAVIORAL EVALUATION OF HOUSEHOLD EXPOSURE TO DURSBAN 1

BASIS-Teen Pilot Project

Neuropsychological Correlates of Performance Based Functional Status in Elder Adult Protective Services Referrals for Capacity Assessments

Progression of motor subtypes in Huntington s disease: a 6-year follow-up study

Unified Huntington s Disease Rating Scale: clinical practice and a critical approach

Introduction to Huntington s Disease. Huntington s Disease Society of America Center of Excellence at UC Davis June 4, 2013

Denial and Unawareness in Huntington s Disease

Development of methodology for conducting clinical trials in frontotemporal lobar degeneration

Early intervention in Bipolar Disorder

Table 2B: Summary of Select Screening and Initial Assessment Tools for Vascular Cognitive Impairment in Stroke Patients (Updated 2014)

Mending the Mind: treatment of the severely mentally ill

Neuropsychological Assessment: Applications to the Work Setting

NeuroTracker Published Studies & Research

UDS version 3 Summary of major changes to UDS form packets

Importance of SW s: Billing for LCSW s in Palliative Care (PC) Brandi Rutan, LCSW in. Heidi McIntyre, 8/14/2018. GA/NC and LISW-C-SC

LOUISIANA MEDICAID PROGRAM ISSUED: 04/13/10 REPLACED: 03/01/93 CHAPTER 13: MENTAL HEALTH CLINICS SECTION13.1: SERVICES PAGE(S) 9 SERVICES

02/04/2015. The structure of the talk. Dementia as a motor disorder. Movement, cognition & behaviour. Example 1. Example 2

Cover Page. The handle holds various files of this Leiden University dissertation

Huntington s Disease Patients Have Selective Problems With Insight

Bridgepoint Sinai Health System Toronto Rehabilitation Institute UHN Holland Bloorview Kids Rehabilitation Hospital

MANAGING YOUR COGNITIVE SYMPTOMS. Dr. Valerie Suski University of Pittsburgh Medical Center HDSA COE Director

REPORT OF NEUROPSYCHOLOGICAL ASSESSMENT

NEUROFEEDBACK FOR AFFECT DYSREGULATION AND IMPAIRMENT IN EXECUTIVE FUNCTIONING Hilary Hodgdon, Ph.D. & Ainat Rogel, Ph.D.

Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients

An Approach to Dementia-related Behaviours at the End of Life. Elisabeth Drance MD FRCP(C) Ger. Psych Clinical Associate Professor Psychiatry UBC

Neuropsychological Evaluation of

Pharmacological Treatments for Neuropsychiatric Symptoms in Dementia 3/22/2018

Cognitive remediation in Recent Onset Schizophrenia: Results of an effectiveness trial

The Association Between Comorbidities and Neurocognitive Impairment in Aging Veterans with HIV

Neuropsychiatric consequences of traumatic brain injury. Causes of head injury. Physical symptoms. Outcome (Thornhill et al, 2001)

HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D.

The Neuropsychology of

Caregiver burden is increased in Parkinson s disease with mild cognitive impairment (PD-MCI)

M P---- Ph.D. Clinical Psychologist / Neuropsychologist

The Detection and Treatment of Perinatal Depression in Medical Settings

WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient

Movement Disorders Will Garrett, M.D Assistant Professor of Neurology

Alzheimer s disease dementia: a neuropsychological approach

Neuropsychology. Neuropsychology

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

MOS SF-36 health survey (Ware &

HDSA welcomes you to Caregiver s Corner. Funded by an educational grant from

Words: 1393 (excluding table and references) Exploring the structural relationship between interviewer and self-rated affective

Basal ganglia volume and clinical correlates in preclinical Huntingtons disease

Dementia Support Across the Care Continuum

Supplementary Online Content

Transcription:

Cognitive and Psychiatric Characteristics of Huntington Disease Rosa Ip, PhD, C. Psych, Jean Byers. MD., FRCPC, DABPN, Carol Harren, RN, CNC

Cognitive and Psychiatric Characteristics of Huntington Disease I. Huntington Disease(HD): Overview Clinical Features of HD II. Pilot Study: Cognitive and Psychiatric Data Preliminary Results III. Client/Family Education and Support Continuum of Care

Huntington Disease: Overview A genetically transmitted, progressive neuropsychiatric disorder that can appear at any time in life (autosomal dominant) Symptom onset typically third or fourth decade HD gene locus at the distal end of the short arm of chromosome 4 Gene is an unstable CAG trinucleotide repeat sequence Cells in the caudate nucleus die, affecting neural pathways to other areas of the brain

Huntington Disease: Clinical Features Triad of symptoms: Movement Cognitive Psychiatric

Clinical Features (con t) Any of the 3 can be presenting symptoms Movements are the most specific All patients are eventually affected in all 3 spheres 15-20 year course Aspiration pneumonia is most common cause of death

Psychiatric Features Common symptoms Apathy Irritability Dysphoria Anxiety Common syndromes Mood disorders Intermittent explosive disorder Atypical psychosis (schizophrenia) *Adapted from APA textbook of Neuropsychiatry

Cognitive Symptoms Impaired executive function (planning, organization of sequential actions, mental flexibility) Problems with sustained concentration Impaired visuospatial skills Memory problems, with greater impairment in retrieval than retention Procedural memory deficits

Pilot Study Examined 15 inpatients/outpatients with HD at Ontario Shores Clients were administered the Neuropsychiatric Inventory (NPI), Montreal Cognitive Assessment (MOCA), and neuropsychological tests (Verbal Fluency, Symbol Digit Modalities, Stroop) of the Unified HD Rating Scale Clients age, CAG repeats, and years since diagnoses investigated in relation to their psychiatric and cognitive status

Participant Demographics Mean age: 53.53 (SD=15.39) Gender: 6 males, 9 females Mean years since diagnosis: 10.13 (SD=5.95) Mean CAG repeats: 43 (SD=3.12) Living arrangements: home (8),hospital/LTCF (7)

Variables by Living Arrangement * p < 0.05 ** p < 0.01

Demographics by Living Arrangements n(female) = 5 n (female) = 4 n(male) = 2 n(male) = 4

Cognitive Status by Living Arrangement * ** * * p < 0.05 ** p < 0.01

Scatterplot: Age and CAG repeats Age and NPI Association between Age and CAG repeat, p < 0.01 Association between Age and NPI (Client), p < 0.05

Scatterplot: Yrs Since Dx & Visuospatial/Executive Yrs Since Dx & Attention Association between yrs since dx and MOCA Attention, p < 0.05 Association between yrs since dx and MOCA Visuospatial/Executive, p < 0.05

Neuropsychiatric Inventory (NPI) Caregivers vs. Clients t(14) = 6.25, p < 0.001

Summary: Preliminary Findings Significant differences in cognitive performance between clients living at home and those in hospital/ltcf Visuospatial/Executive & Attention subtests significantly associated with yrs since dx - consistent with HD cognitive profile Clients with HD significantly underestimate their neuropsychiatric impairments compared to caregivers anosognosia Based on findings: Investigation with larger sample size/more variables in progress Predictors of living arrangement using cognitive and other measures will be explored Implications to assist in education of clients/caregivers

Behavioural Changes Diminished self-awareness leads to problems with: Self-determination Self-direction Self-control and regulation Compromised insight and empathy

Managing Behaviour Provision of education Support and follow-up in community Community resources

Continuum of Service: Continuum of Care Key to Success 19 Outreach Services HD Clinic 5 Bed Inpatient Unit

Dr. Jean Byers, Dr. Rosa Ip and Carol Harren RN will be presenting at the 2012 National Conference on HD in Toronto in November